Biogen (BIIB) Reports Strategic Collaboration with Skyhawk Therapeutics to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets

January 4, 2019 7:32 AM
Biogen Inc (NASDAQ: BIIB) and Skyhawk Therapeutics, Inc. today announced a strategic collaboration in which the companies will leverage Skyhawk’s ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)


Corporate News Management Comments

Next Articles